Selenium and the Course of Mild Graves' Orbitopathy

2011602 citationsJournal Articlebronze Open Access

Authors

Claudio Marcocci · University of Pisa

George J. Kahaly · Johannes Gutenberg University Mainz

Gerasimos E Krassas · Shirasagi Hospital

Luigi Bartalena · University of Insubria

Mark F. Prummel

Matthias Stahl · Academic Medical Center

Maria Antonietta Altea

Marco Nardi

Abstract

Selenium administration significantly improved quality of life, reduced ocular involvement, and slowed progression of the disease in patients with mild Graves' orbitopathy. (Funded by the University of Pisa and the Italian Ministry for Education, University and Research; EUGOGO Netherlands Trial Register number, NTR524.).

Topics & Keywords

Selenium in Biological Systems Medical and Biological Ozone Research Biomedical Research and Pathophysiology

Publication Details

Published in: New England Journal of Medicine

Volume 364, Issue 20, pp. 1920-1931

DOI: 10.1056/nejmoa1012985

Field-Weighted Citation Impact: 28.84

Command Palette

Selenium and the Course of Mild Graves' Orbitopathy

Authors

Abstract

Topics & Keywords

Publication Details